Search results for " MICROENVIRONMENT"

showing 10 items of 359 documents

Hyaluronic Acid Present in the Tumor Microenvironment Can Negate the Pro-apototic Effect of a Recombinant Fragment of Human Surfactant Protein D on B…

2020

Copyright © 2020 Murugaiah, Agostinis, Varghese, Belmonte, Vieni, Alaql, Alrokayan, Khan, Kaur, Roberts, Madan, Bulla and Kishore. Human surfactant protein D (SP-D) belongs to the family of collectins that is composed of a characteristic amino-terminal collagenous region and a carboxy-terminal C-type lectin domain. Being present at the mucosal surfaces, SP-D acts as is a potent innate immune molecule and offers protection against non-self and altered self-such as pathogens, allergens, and tumour. Here, we examined the effect of a recombinant fragment of human SP-D (rfhSP-D) on a range of breast cancer lines. Breast cancer has four molecular subtypes characterised by varied expression of oes…

lcsh:Immunologic diseases. Allergy0301 basic medicinesurfactant protein DImmunologyCollectinApoptosisBreast Neoplasms03 medical and health sciencesbreast cancer0302 clinical medicineEpidermal growth factorCell Line Tumorhyaluronic acidTumor MicroenvironmentHumansImmunology and Allergyskin and connective tissue diseasesinnate immunityOriginal ResearchTumor microenvironmentChemistryimmune surveillanceIntrinsic apoptosisCell cyclePulmonary Surfactant-Associated Protein DRecombinant Proteins030104 developmental biologyApoptosisCell cultureSKBR3Cancer researchFemalelcsh:RC581-607030215 immunologyFrontiers in Immunology
researchProduct

Is the Complement Protein C1q a Pro- or Anti-tumorigenic Factor? Bioinformatics Analysis Involving Human Carcinomas

2019

C1q is the first subcomponent of the classical pathway of the complement system and belongs to the C1q/Tumor Necrosis Factor superfamily. C1q can perform a diverse range of immune and non-immune functions in a complement-dependent as well as -independent manner. Being a pattern recognition molecule of the innate immunity, C1q can recognize a number of self, non-self and altered-self ligands and bring about effector mechanisms designed to clear pathogens via opsonisation and inflammatory response. C1q is locally synthesized by macrophages and dendritic cells, and thus, can get involved in a range of biological processes, such as angiogenesis and tissue remodeling, immune modulation, and immu…

lcsh:Immunologic diseases. Allergy0301 basic medicinetumorLung NeoplasmsMicroenvironmentPrognosiImmunologyComplementBreast Neoplasmschemical and pharmacologic phenomenaKaplan-Meier EstimateBiology03 medical and health sciencesClassical complement pathway0302 clinical medicineImmune systemimmune system diseasesmedicineHumansImmunology and Allergycomplementclassical pathwayskin and connective tissue diseasesC1qOriginal ResearchTumorInnate immune systemEffectorComplement C1qComputational BiologyCancerPrognosismedicine.diseasemicroenvironmentKidney NeoplasmsComplement systemClear cell renal cell carcinomaC1q; Classical pathway; Complement; Microenvironment; Prognosis; Tumor030104 developmental biologyClassical pathwayCancer researchAdenocarcinomaprognosislcsh:RC581-607030215 immunologyFrontiers in Immunology
researchProduct

Tumor-Infiltrating γδ T Lymphocytes: Pathogenic Role, Clinical Significance, and Differential Programing in the Tumor Microenvironment.

2014

There is increasing clinical evidence indicating that the immune system may either promote or inhibit tumor progression. Several studies have demonstrated that tumors undergoing remission are largely infiltrated by T lymphocytes [tumor-infiltrating lymphocytes (TILs)], but on the other hand, several studies have shown that tumors may be infiltrated by TILs endowed with suppressive features, suggesting that TILs are rather associated with tumor progression and unfavorable prognosis. γδ T lymphocytes are an important component of TILs that may contribute to tumor immunosurveillance, as also suggested by promising reports from several small phase-I clinical trials. Typically, γδ T lymphocytes …

lcsh:Immunologic diseases. AllergyImmunologyReview Articleγδ T cellspolarization.Immune systemImmunesuppressionImmunology and AllergyMedicinetumor microenvironmentCytotoxicityTumor microenvironmentimmunosuppressionbusiness.industryCancerDendritic cellT lymphocyteTILmedicine.diseasegamma delta cellIL-17Tumor progressionImmunologygd T cellsInterleukin 17businesslcsh:RC581-607Frontiers in immunology
researchProduct

Nanomedicine and macroscale materials in immuno-oncology

2019

Immunotherapy is revolutionizing the treatment of cancer. It can achieve unprecedented responses in advanced-stage patients, including complete cures and long-term survival. However, immunotherapy also has limitations, such as its relatively low response rates and the development of severe side effects. These drawbacks are gradually being overcome by improving our understanding of the immune system, as well as by establishing combination regimens in which immunotherapy is combined with other treatment modalities. In addition to this, in recent years, progress made in chemistry, nanotechnology and materials science has started to impact immuno-oncology, resulting in more effective and less t…

medicine.medical_specialtyChemistry(all)Macromolecular Substancesmedicine.medical_treatmentContext (language use)02 engineering and technologyArticle03 medical and health sciencesNeoplasmsmedicineHumansIntensive care medicine030304 developmental biology0303 health sciencesTumor microenvironmentbusiness.industryNeoplasms therapyGeneral ChemistryImmunotherapy021001 nanoscience & nanotechnologyn/a OA procedure3. Good healthNanomedicineTreatment modalityNanomedicineImmunotherapy0210 nano-technologybusiness
researchProduct

Obesity, an independent predictor of pre and postoperative tumor grading disagreement in endometrial cancer

2021

Abstract Introduction Obesity is a known independent risk factor for endometrial cancer (EC), and obese patients have a 4.7-fold increased risk compared to the general population to develop the neoplasm. To date, a general pre and postoperative tumor grading agreement from 53 % to 82 % is reported for endometrial analysis, and a consensus on which factors might influence the tumor grading discordance is still absent. Furthermore, although obesity alters the endometrial microenvironment, no studies investigated the role of obesity in the grading agreement of EC patients. This study aims to analyze the role of obesity in the pre and postoperative tumor grading agreement. Materials and methods…

medicine.medical_specialtyMultivariate analysisBiopsyConcordancePopulationGastroenterology03 medical and health sciences0302 clinical medicineInternal medicineTumor MicroenvironmentmedicineHumansObesity030212 general & internal medicineRisk factoreducationGrading (tumors)Retrospective Studieseducation.field_of_study030219 obstetrics & reproductive medicinebusiness.industryEndometrial cancerObstetrics and GynecologyCancerOdds ratiomedicine.diseaseEndometrial NeoplasmsReproductive MedicineFemaleNeoplasm GradingbusinessEuropean Journal of Obstetrics & Gynecology and Reproductive Biology
researchProduct

Oral complaints in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation

2021

Background Acute myeloid leukemia belongs to proliferative diseases of the hematopoietic system. It is currently the leading indication for allogeneic hematopoietic stem cell transplantation. This study was designed to determine the most common subjective oral mucosa complaints in patients with acute myeloid leukemia after allogeneic hematopoietic cell transplantation, in relation to the type of conditioning used. Material and Methods Eighty patients diagnosed with acute myeloid leukemia were assigned to two groups depending on the intensity of the conditioning regimen before transplantation: myeloablative and reduced-intensity chemotherapy. The oral symptoms were evaluated based on an auth…

medicine.medical_specialtyTransplantation Conditioningmedicine.medical_treatmentGraft vs Host DiseaseHematopoietic stem cell transplantationInternal medicineMedicineHumanstumor microenvironmentdendritic cellsOral mucosaGeneral DentistryUNESCO:CIENCIAS MÉDICASRetrospective StudiesChemotherapyOral Medicine and Pathologybusiness.industryResearchHematopoietic Stem Cell TransplantationMyeloid leukemiaoral cancerDysgeusiaTransplantationclec9aHaematopoiesisLeukemia Myeloid Acutemedicine.anatomical_structureOtorhinolaryngologyTaste disorderQuality of LifeSurgeryimmunotherapymedicine.symptombusiness
researchProduct

Immunologic microenvironment and personalized treatment in multiple myeloma.

2013

Introduction: Multiple myeloma (MM) is characterized by generalized immune suppression and increased susceptibility to infections and secondary malignancies. Malignant plasma cells (PCs) modulate the bone marrow microenvironment to favor their own survival and proliferation. These events lead to a severe deregulation of immune effectors. Extensive studies have been conducted to unveil the mechanisms through which MM cells negatively modulate immunity and to develop therapeutical approaches for restoring an efficient anti-MM immune response. Areas covered: This review article covers both the immunosuppressive effects exerted by MM and the immunomodulatory potential of novel anti-MM agents. A…

medicine.medical_treatmentClinical BiochemistryAntineoplastic AgentsImmune systemImmunityDrug DiscoveryTumor MicroenvironmentMedicineHumansPrecision MedicineMultiple myelomaBone marrow microenvironmentPharmacologyTumor microenvironmentbusiness.industryImmunotherapymedicine.diseaseReview articlemedicine.anatomical_structurePersonalized treatmentImmune SystemImmunologyBone marrowPersonalized medicineImmunotherapybusinessMultiple MyelomaExpert opinion on biological therapy
researchProduct

Delivery of siHIF‐1α to Reconstruct Tumor Normoxic Microenvironment for Effective Chemotherapeutic and Photodynamic Anticancer Treatments

2021

The tumor hypoxic microenvironment not only induces genetic and epigenetic changes in tumor cells, immature vessels formation for oxygen demand, but also compromises the efficiency of therapeutic interventions. On the other hand, conventional therapeutic approaches which kill tumor cells or destroy tumor blood vessels to block nutrition and oxygen supply usually facilitate even harsher microenvironment. Thus, simultaneously relieving the strained response of tumor cells and blood vessels represents a promising strategy to reverse the adverse tumor hypoxic microenvironment. In the present study, an integrated amphiphilic system (RSCD) is designed based on Angiotensin II receptor blocker cand…

medicine.medical_treatmentPhotodynamic therapy02 engineering and technology010402 general chemistry01 natural sciencesBiomaterialsNeovascularizationchemistry.chemical_compoundIn vivoCell Line TumorTumor MicroenvironmentmedicineHumansGeneral Materials ScienceRNA Small InterferingHypoxiaChemotherapyTumor microenvironmentGeneral ChemistryHypoxia-Inducible Factor 1 alpha Subunit021001 nanoscience & nanotechnologyCell HypoxiaIn vitro0104 chemical sciencesOxygenchemistryDrug deliveryCancer researchmedicine.symptomGrowth inhibition0210 nano-technologyBiotechnologySmall
researchProduct

Harnessing dendritic cells in cancer.

2011

Dendritic cells (DCs) are central to the initiation of tumor-specific immune responses. However, the tumor microenvironment generates immunosuppressive cells and soluble mediators that compromise DC functions and limit the success of DC-based therapies. Progress in understanding DC metabolism in cancer is uncovering novel therapeutic targets that could restore DC capacity to prime T cells and trigger effective anticancer responses. Accumulating evidence also indicates that conventional chemo- and radiotherapy protocols can cause DC activation, enhance antigen cross-presentation, selectively eliminate immunosuppressive cells and revert the immunosuppression state caused by cancer, suggesting…

medicine.medical_treatmentT-LymphocytesImmunologyAntineoplastic AgentsBiologyLymphocyte ActivationCancer VaccinesImmune systemAntigenChemoimmunotherapyAntigens NeoplasmNeoplasmsmedicineTumor MicroenvironmentImmunology and AllergyAnimalsHumansTumor microenvironmentInnate immune systemCancerImmunotherapyDendritic CellsAcquired immune systemmedicine.diseaseCell biologyKiller Cells NaturalDisease Models AnimalImmunotherapySeminars in immunology
researchProduct

Potential Roles of Muscle-Derived Extracellular Vesicles in Remodeling Cellular Microenvironment: Proposed Implications of the Exercise-Induced Myoki…

2021

Extracellular vesicles (EVs) have emerged as key players of intercellular communication and mediate crosstalk between tissues. Metastatic tumors release tumorigenic EVs, capable of pre-conditioning distal sites for organotropic metastasis. Growing evidence identifies muscle cell-derived EVs and myokines as potent mediators of cellular differentiation, proliferation, and metabolism. Muscle-derived EVs cargo myokines and other biological modulators like microRNAs, cytokines, chemokines, and prostaglandins hence, are likely to modulate the remodeling of niches in vital sites, such as liver and adipose tissues. Despite the scarcity of evidence to support a direct relationship between muscle-EVs…

muscleCellular differentiationmyokinesInflammationReviewBiologyMetastasisCell and Developmental BiologymicroRNAMyokinemedicinelcsh:QH301-705.5tumor metastasisCancerCell Biologytissue microenvironmentmedicine.diseaseCell biologyCrosstalk (biology)homing nichelcsh:Biology (General)integrinsmedicine.symptomextracellular vesiclesirisinDevelopmental BiologyHoming (hematopoietic)Frontiers in Cell and Developmental Biology
researchProduct